www.fdanews.com/articles/176276-act-toray-sign-agreement-on-innovative-catheter-technology
![Signing](https://www.fdanews.com/ext/resources/test/Drug-Images/signing.jpg?t=1620076341&width=430)
ACT, Toray Sign Agreement on Innovative Catheter Technology
April 19, 2016
Advanced Catheter Therapies and Toray Industries have inked a license agreement to manufacture, market and sell Occlusion Perfusion Catheter.
The FDA-cleared OPC is a targeted therapeutic agent delivery system for peripheral vascular stenosis and restenosis.
The OPC is a multi-lumen balloon catheter designed to provide targeted delivery — creating a localized treatment chamber — of various therapeutic and diagnostic agents to the peripheral and coronary vasculature by temporarily occluding a specific region from blood flow. — Joya Patel